When was CoreBiome founded?

CoreBiome was founded in 2016 and raised its 1st funding round 1 year after it was founded.

Where is CoreBiome located?

CoreBiome is headquartered in Minneapolis, United States.

Is CoreBiome a funded company?

CoreBiome is a funded company, having raised a total of $1.35M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jul 05, 2017.

When was the latest funding round of CoreBiome?

CoreBiome's latest funding was a $***** Seed round on Aug 29, 2018, with participation from 0 investor. Its primary sector is Genomics. In United States, the Genomics sector has seen $424M in funding in 2026 to date.

Where does CoreBiome rank among its competitors?

CoreBiome ranks 128th amongst 458 active competitors, of which 99 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was SeqOne, which secured $22.7M in May, 2025.

Who are the top competitors of CoreBiome?

CoreBiome's top competitors include Deep Genomics, Hexagon Bio and Trace Genomics. Among them, SeqOne secured the most recent funding round in May, 2025.

CoreBiome - 2026 Company Profile, Funding & Competitors

Company Details

CoreBiome provides develops proprietary methods and accompanying analytics enable the precise measurement and interpretation of microbial diversity. The company offers end-to-end solutions from sample processing, through DNA sequencing and advanced and extensive data analysis using AI and ML based analytics approaches.

Website: corebiome.com
Email ID: *****@corebiome.com

Key Metrics

Founded Year

2016

Location

Minneapolis, United States

Stage

Acqui-Hired

Total Funding

$1.35M in 2 rounds

Latest Funding Round

Seed, Aug 29, 2018, $*****

Investors

Gopher Angels & 2 more

Ranked

128^th among 458 active competitors

Similar Companies

Deep Genomics & 629 more

View CoreBiome's full profile

CoreBiome has raised a total funding of $1.35M over 2 rounds. Its first funding round was on Jul 05, 2017. CoreBiome has 2 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of CoreBiome:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 29, 2018	5006484	Seed	8449506	2882382	8972449	1953145
Jul 05, 2017	7489981	Seed	6383768	7295003	Gopher Angels & 1 more	7690627

Access funding benchmarks and valuations. Sign up today!

View details of CoreBiome's funding rounds and investors

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of CoreBiome include Deep Genomics, Hexagon Bio and Trace Genomics. Here is the list of Top 10 competitors of CoreBiome, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Deep Genomics 2014, Toronto (Canada), Series C	AI-powered platform for RNA biology to accelerate genetic therapy discovery	$238M	SoftBank Vision Fund, Khosla Ventures & 16 others	63/100
2nd	Hexagon Bio 2017, Menlo Park (United States), Series B	Provider of bioinformatics tools for the analysis of microbial genomic sequencing data	$206M	The Column Group, Nextech Invest & 10 others	63/100
3rd	Trace Genomics 2015, Ames (United States), Series B	Provider of soil intelligence technology for sustainable agriculture and food	$53.6M	THRIVE, S2G Investments & 18 others	60/100
4th	Biotia 2016, Brooklyn (United States), Series A	Provider of sequencing-based solutions for hospitals	$10.4M	Leawood Venture Capital, OCA Ventures & 16 others	59/100
5th	Kallyope 2014, New York City (United States), Series D	Discovering novel therapeutics for neurological and metabolic diseases	$479M	The Column Group, Lux Capital & 21 others	59/100
6th	BC Platforms 1997, Zurich (Switzerland), Series D	Provider of a platforms for genomic data analysis and management	$47.1M	Tesi, Debiopharm & 6 others	58/100
7th	SeqOne 2017, Montpellier (France), Series A	Provider of bioinformatics tools for the analysis of genome sequencing data	$48.8M	Omnes Capital, Elaia & 7 others	58/100
8th	Molecular Health 2004, Heidelberg (Germany), Late Stage	Genomic software solutions for healthcare providers	$26.9M	Dievini, The University of Texas at Austin ... & 1 others	56/100
9th	Linus Biotechnology 2020, New York City (United States), Series A	Developer of diagnostic tests for central nervous system and gastrointestinal disorders	$47.6M	GreatPoint Ventures, Bow Capital & 3 others	55/100
10th	Broken String Biosciences 2020, Cambridge (United Kingdom), Series A	Developer of biopharmaceutical products & cell therapies by using genome sequencing data	$15M	Dieter von Holtzbrinck Ventures, Illumina ... & 14 others	55/100
128th	CoreBiome 2016, Minneapolis (United States), Acqui-Hired	Microbiome analysis solutions using big data approaches	$1.35M	Gopher Angels, Gbeta & 1 others	32/100